Haemonetics (HAE) Other Operating Expenses (2010 - 2026)

Haemonetics has reported Other Operating Expenses for 14 years, with the latest figure at $85.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 832.2% year-over-year to $85.9 million; the trailing twelve-month figure through Mar 2026 stood at $128.7 million (up 365.67% YoY), and the FY2026 full-year result was $128.7 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $85.9 million, up from $11.6 million in the prior quarter.
• The five-year high for Other Operating Expenses was $85.9 million in Q1 2026, with the low at -$11.7 million in Q1 2025.
• Average Other Operating Expenses over 5 years is $15.3 million, with a median of $11.6 million recorded in 2025.
• Year-over-year, Other Operating Expenses surged 1790.58% in 2023 and slumped 156.26% in 2025.
• Tracing HAE's Other Operating Expenses over 5 years: stood at $382000.0 in 2022, then soared by 1709.16% to $6.9 million in 2023, then surged by 76.96% to $12.2 million in 2024, then fell by 4.75% to $11.6 million in 2025, then jumped by 637.04% to $85.9 million in 2026.
• The last three Other Operating Expenses figures came in at $85.9 million (Q1 2026), $11.6 million (Q4 2025), and $19.8 million (Q3 2025), per Business Quant data.

Peer Comparison